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Effects of purtfied subtypes I. II and III of protem kmase C (PKC) on voltage-dependent transient K+ (A) and Na+ channels were studied m 
Xcnopus oocytes injected with chick bram RNA. The experiments were performed in the constant presence of 10 nM p-phorbol 12-myrtstate-13- 
acetate (PMA) Intracellular injectton of subtype I (5) reduced the A-current (IA). wtth no effect on Na+ current (INa). PKC subtype II (J, +/3,) 
and III (n) reduced both currents PKC did not affect the response to kainate Inacttvated (heated) or unacttvated (injected m the absence of PMA) 
enzyme and vehtcle alone had no effect. Our results strongly suggest that 1,, and IA m vertebrate neurons are modulated by PKC. all PKC subtypes 
exert a stmilar effect on the A-channel while only subtypes II and III modulate the Na+ channel 
Protem kmase C isoform, Sodmm channel, A channel, RNA expression: Modulation; Oocyte; Xenopus 
1. INTRODUCTION 
Although voltage-activated Naf and A-type K+ 
channels are among the most abundant and important 
ion channels in the brain, little is known about their 
modulation [l-5]. There are indications that, like many 
other ion channels [3], IA and ZN~ may be modulated by 
the ubiquitous protein kinase C (PKC), which is ac- 
tivated by a variety of neurotransmitters [6,7]. Thus, 
purified brain Na+ channel is phosphorylated by PKC 
[2]; phorbol esters (PKC activators) inhibit IN= express- 
ed in Xenopus oocytes injected with chick brain RNA 
[8]; c&fatty acids reduce ZNa in mouse neuroblastoma 
cells, apparently via PKC activation [9]. PKC activators 
reduce IA in heart, glial cells and neurons [lo-l 31. 
Modulation of IA by purified PKC has been studied on- 
ly in molluscan neurones, where purified heterologous 
PKC reduces IA [ 131. Moreover, the roles of the recently 
discovered isoforms (subtypes) of PKC are unclear. It 
has been proposed that subspecies of PKC may (at least 
in part) account for the diversity of cellular effects of 
PKC, e.g. different modulations of ion channels 
[14,15]. However, differential effects of the PKC 
subspecies purified to date have been demonstrated on- 
ly in one case: gonadotropin secretion in cultured 
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pituitary cells [16]. Effects of PKC subspecies on ion 
channels have not been studied. 
We have examined the effects of phorbol esters and 
of purified PKC subspecies on IA and IN= from chick 
brain expressed in RNA-injected Xenopus oocytes, 
which proved to be a good model system to study 
modulation of ion channels [8,17-221. We have found 
that both PKC activators and the purified PKC reduce 
these currents, and there is a certain specificity of the 
different subtypes towards the Na, but not A, channel. 
2. EXPERIMENTAL 
Frogs were maintained and dissected and the oocytes prepared as 
described 1231. Total RNA was isolated from brains of 19.day chick 
embryos by LtCl/urea method [24]. The oocytes were injected with 50 
nl of total RNA (6-10 mg/ml m water), and Incubated for 2-5 days 
at 22°C in sterile ND96 solution [22] (96 mM NaCI, 2 mM KCI, 1.8 
mM CaCl2, I mM MgCl2, 5 mM Hepes/NaOH; pH 7.5) sup- 
plemented with 100 umts/ml pemcillin, 100 pg/ml streptomycin and 
2.5 mM sodium pyruvate, with or without phorbol-12-myristate- 
13-acetate (PMA) or phorbol-12,13-dtbutyrate (PDBu). The currents 
were recorded using the two-electrode voltage-clamp method [18,22] 
in ND96 solution with the addition of 2 mM 9-antracenecarboxylic 
acid (to block Cl- channels [25]) and 20 or 30 mM tetraethylam- 
momum chloride. The routine protocols to measure the currents were 
as follows. Net Iq was obtained by recording currents evoked by 
voltage steps from ~ 100 mV (5 s prepulse) to 40 mV (test pulse) and 
subtraction of currents evoked by voltage steps from - 50 mV to 40 
mV [26]. Net INS was obtained by recording currents evoked by 
voltage steps from ~ 100 to ~ 10 mV, and subtraction of currents 
evoked by voltage steps from - 20 to - 10 mV [26]. Both currents 
were recorded in the same cell. The estimates of each current were not 
significantly affected by the presence of the other one because: (i) at 
40 mV, at which IA was measured, 1~~ is negligible; (ii) at - 10 mV, 
the peak of 1~~ occurs while I& only starts rising, and IA is usually 
more than j-fold smaller than 1~~ [26]. 
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Type I and III PKCs were purified to homogeneity from adult male 
rat brains as described [27,28]; type II was partially purlfled as 
described [29] and found to be free of activny of CAMP-and 
Ca/calmodulin-dependent protein kinases. The identity of the PKCs 
was confirmed with type-specific antibodies [28,29]. The PKCs were 
diluted at about 20 ng/Fl m buffer contammg 20 mM Tris (pH 7.5). 
0.5 mM EDTA. 0.5 mM EGTA, 10 mM fi-mercaptoethanol, 0.01% 
Trlton X-100, and 10% glycerol and stored In small ahquots at 
- 70°C. 4.5 nl of the enzyme or vehicle (about 0.5% of the oocyte’? 
volume) were pressure-injected Into the oocytes as described [33] All 
PKCs had approximately the same specific activity; the activity of 
PKC Introduced into an oocye by a smgle injection was approximately 
8x lo-” mol/min (measured by incorporation of “P, into HI 
hlstone from [Y-~‘P]ATP at 30°C) [16] The acti\ltj of the en- 
dogenous PKC in the oocytes was measured m homogenates of 
100-200 oocyter. 
3. RESULTS AND DISCUSSION 
I N=, IA and the response to kainate (Ika,nafe) were 
characterized previously [26]. Currents were recorded 
with the two-electrode voltage-clamp technique. PMA 
and PDBu reduced INS, had no effect on &a&e, in ac- 
cord with [8], and also reduced [A. 20-30 min after ap- 
plication, 10 nM PMA reduced INa and IA to 47 + 9% 
(n = 5) and 88 + 3% (n = 5) of control before PMA addi- 
tion, respectively (all data are mean f SE). No signifi- 
cant changes in oocyte capacitance during this time 
have been observed, suggesting that the surface area 
was unchanged. Similar results were obtained with 
50-100 nM PDBu. We also observed changes in voltage 
dependency of activation and inactivation of INS (to be 
reported elsewhere). 
The effect of phorbol esters were assumed to be 
mediated by the oocytes’ endogenous PKC (native or 
directed by the brain RNA). To avoid interference of 
the endogenous PKC when injecting the exogenous 
PKC, the routine protocol included 30-48 h incubations 
of the oocytes with 10 nM PMA or 50 nM PDBu (higher 
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Fig. 1. The effects of inJectIon of PKC (type 111) on IN,, (A) and I,% (B) 
in the presence of 10 nM PMA. after a 38 h prelncubation in PMA. 
The currents denoted by ‘PKC’ were recorded 20 mm after the 
inJection of PKC. Net Iha was measured at - 10 mV by subtraction 
of currents obtained m the presence of 100 nM tetrodotowin; net IA 
was measured at + 40 mV as explamed in sectIon 2. 
concentrations were lethal or reduced the oocytes’ 
capacitance, in accord with [3O]). 14 and INa were then 
recorded in the continuous presence of the same con- 
centration of the phorbol ester. Under these conditions, 
the currents were steady for tens of minutes (before the 
Table 1 
Effects of protem kinase C on I\, 1~~ and IL,,,,,,, 
Active enzymes Conirols 
Type III Type II Type 1 Mixture* Vehicle Unactuated Inactivated 
I + II + I11 type II1 type 111 
IA 67 t 4(11) 63 + 4 (8) 72 + 3 (II) 73 (66,SO) (2) 93 i 2 (15) 91 * 4 (4) 93 ? 2 (6) 
P<O.OOl P<O.OOl P<O.OOl 
ha 77 k 6 (11) 
P<O.Ol 
68 i 8 (5) 
P< 0.02 
100 f 6 (8) 94 * 10 (3) 93 + 3 (8) 101 4 2 (3) 103 i 3 (5) 
PzO.2 
Lmt, 98 rf 4 (4) 100. 100 (2) 
*Stoichiometric mixture of the 3 subtypes; the concentration of each one was one-thn-d of that used m inJections of Individual subtypes 
Current, recorded 20-30 min after the Injection were eapres5ed m percent of the currents before the injection, m the rame cell. The numbers are 
mean & SE and number of cells IS indicated in parenthe,ea. The atablhty of the current before the mjectlon wa\ verified during at least 10 min. 
After the insertion of PKC-contaimng mjectlon needle, the amplitude of I~ and I ~~ sometimes changed; m thebe cases. ?tabihty of the currents’ 
amplitude at the neu level was again verified as above. If one of the tested currents was not stable withm 5%. the results were dlszarded. The 
significance of the effects of protein kinase subtypes was calculated ualng two-tailed Student’s t-test. The effects of types 1 and 11 were compared 
with those of the vehrcle, whereas the effects of type III were compared with those of the inactivated and of the unactlvated enzyme (Identical 
probability levels were obtamed m both cases). 
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injection of PKC). The endogenous PKC in these 
oocytes was down-regulated by 75 f 15% (n = 3). These 
results suggest that, although full down-regulation (see 
[7]) of endogenous PKC did not always occur, a steady- 
state has been achieved in which the currents were not 
affected anymore by the presence of phorbol esters at 
the concentration employed. 
Injection of PKC II and PKC III reduced both ZN~ 
and IA by 20-40% on the average after 20-40 min 
(Table I, Fig. lA,B, and Fig. 2A). PKC I had a dif- 
ferent effect: it reduced la, but produced no change in 
ZNa (Fig. 2B), although increases or decreases (range: 
76-140% of control) were observed in individual 
oocytes. These results imply that PKC I may have a 
dual effect on INS, e.g. by phosphorylating two dif- 
ferent sites on the channel molecule, but testing of this 
assumption requires further study. The responses to 
kainate in the same cells were not altered by PKC injec- 
tion (Table I). We did not find evidence for synergism 
between PKC subtypes, since a stoichiometric mixture 
of all 3 subtypes reduced ZA to about the same extent as 
the individual subtypes, and did not reduce ZN~ (Table 
I). The latter probably reflects the combined influence 
A 1 PKC”’ 
of all subtypes, supporting the possibility that PKC I 
may sometimes enhance INa. 
The time course of the effects of PKCs is shown in 
Fig. 2A,B. In most cases, the main reduction in the cur- 
rents occurred within a few minutes. 
Injection of vehicle (the buffer in which PKC was 
dissolved) produced a small reduction of IA (7070, 
P<O.OOl) and IN= (670, 0.1 >P>O.O5) (Fig. 2C). 
Therefore, the statistical analysis has been done by 
comparing the effects of all PKC subtypes with those of 
the vehicle, and for PKC III (which had marked effects 
on both currents), with additional controls. Injection of 
inactivated PKC III (heated to 65°C overnight and then 
stored for several days at room temperature) had the 
same effects as the vehicle (Fig. 2E). ‘Unactivated’ PKC 
III (enzyme injected into cells not pretreated with 
PMA, in the absence of any added PKC activator) had 
no effect on any of the currents (Fig. 2D). Table I sum- 
marizes the results of all injection experiments. 
Our results demonstrate that the vertebrate neuronal 
voltage-dependent Na+ and K+ channels are 
modulated by PKC. This is the first direct demonstra- 
tion of modulation of ZN~ by purified PKC. Reduction 
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Fig. 2. The trme course of the effects of Injection of PKC and of control soluttons. In all cases, except D, the oocytes were incubated in 10 nM 
PMA before and during the recording sessron, as described in the text. (A) PKC III. (8) PKC 1. (C) vehicle alone. (D) ‘unactivated’ PKC (in the 
absence of PMA). (E) PKC III inactrvated by heating (see text). 
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of vertebrate IA by PKC is similar to that found in 
molluscan neurones [ 131, although we did not observe 
potentiation of IA by PKC in the absence of activators. 
Another interesting finding is that PKC subtypes may 
differentially modulate the same cellular process (Naf 
channel), while in other cases, the heterogeneity of PKC 
subtypes may have no physiological meaning (A- 
channel). The differential distribution of PKC subtypes 
in brain neurones [14], together with the differential 
physiological activities of the subtypes, may play a role 
in the multitude of the effects by PKC-activating 
transmitters. 
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